Literature DB >> 19624168

Profiling human serum antibodies with a carbohydrate antigen microarray.

Oyindasola Oyelaran1, Lisa M McShane, Lori Dodd, Jeffrey C Gildersleeve.   

Abstract

Carbohydrate antigen arrays (glycan arrays) have been recently developed for the high-throughput analysis of carbohydrate macromolecule interactions. When profiling serum, information about experimental variability, interindividual biological variability, and intraindividual temporal variability is critical. In this report, we describe the characterization of a carbohydrate antigen array and assay for profiling human serum. Through optimization of assay conditions and development of a normalization strategy, we obtain highly reproducible results with a within-experiment coefficient of variation (CV) of 10.8% and an overall CV (across multiple batches of slides and days) of 28.5%. We also report antibody profiles for 48 human subjects and evaluate for the first time the effects of age, race, sex, geographic location, and blood type on antibody profiles for a large set of carbohydrate antigens. We found significant dependence on age and blood type of antibody levels for a variety of carbohydrates. Finally, we conducted a longitudinal study with a separate group of 7 serum donors to evaluate the variation in anti-carbohydrate antibody levels within an individual over a period ranging from 3 to 13 weeks and found that, for nearly all antigens on our array, antibody levels are generally stable over this period. The results presented here provide the most comprehensive evaluation of experimental and biological variation reported to date for a glycan array and have significant implications for studies involving human serum profiling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19624168      PMCID: PMC2738755          DOI: 10.1021/pr900515y

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  38 in total

1.  Resolving conflicting data on expression of the Tn antigen and implications for clinical trials with cancer vaccines.

Authors:  Qian Li; Miriam R Anver; Donna O Butcher; Jeffrey C Gildersleeve
Journal:  Mol Cancer Ther       Date:  2009-04       Impact factor: 6.261

2.  Quantity of hemolytic anti-A and anti-B in individuals of a human population: correlations with isoagglutinins and effects of the individual's age and sex.

Authors:  F J Grundbacher
Journal:  Z Immunitatsforsch Allerg Klin Immunol       Date:  1967-12

3.  The relationship of race, sex, and age to concentrations of serum immunoglobulins expressed in international units in healthy adults in the USA.

Authors:  S E Maddison; C C Stewart; C E Farshy; C B Reimer
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

4.  Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptides.

Authors:  S von Mensdorff-Pouilly; E Petrakou; P Kenemans; K van Uffelen; A A Verstraeten; F G Snijdewint; G J van Kamp; D J Schol; C A Reis; M R Price; P O Livingston; J Hilgers
Journal:  Int J Cancer       Date:  2000-06-01       Impact factor: 7.396

Review 5.  Profiling the immune responses in patient sera with peptide and cDNA display libraries.

Authors:  M Sioud; M Hansen; A Dybwad
Journal:  Int J Mol Med       Date:  2000-08       Impact factor: 4.101

6.  Carbohydrate microarrays for the recognition of cross-reactive molecular markers of microbes and host cells.

Authors:  Denong Wang; Shaoyi Liu; Brian J Trummer; Chao Deng; Aili Wang
Journal:  Nat Biotechnol       Date:  2002-03       Impact factor: 54.908

7.  Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays.

Authors:  Sacha Gnjatic; Colin Wheeler; Martin Ebner; Erika Ritter; Anne Murray; Nasser K Altorki; Cathy A Ferrara; Henry Hepburne-Scott; Sarah Joyce; Jens Koopman; Michael B McAndrew; Nicholas Workman; Gerd Ritter; Rachel Fallon; Lloyd J Old
Journal:  J Immunol Methods       Date:  2008-11-28       Impact factor: 2.303

8.  A new kind of carbohydrate array, its use for profiling antiglycan antibodies, and the discovery of a novel human cellulose-binding antibody.

Authors:  Mikael Schwarz; Larissa Spector; Ari Gargir; Avraham Shtevi; Monica Gortler; Rom T Altstock; Avinoam A Dukler; Nir Dotan
Journal:  Glycobiology       Date:  2003-07-08       Impact factor: 4.313

9.  Application of carbohydrate microarray technology for the detection of Burkholderia pseudomallei, Bacillus anthracis and Francisella tularensis antibodies.

Authors:  N Parthasarathy; R Saksena; P Kováč; D Deshazer; S J Peacock; V Wuthiekanun; H S Heine; A M Friedlander; C K Cote; S L Welkos; J J Adamovicz; S Bavari; D M Waag
Journal:  Carbohydr Res       Date:  2008-06-14       Impact factor: 2.104

10.  Profound influence of microarray scanner characteristics on gene expression ratios: analysis and procedure for correction.

Authors:  Heidi Lyng; Azadeh Badiee; Debbie H Svendsrud; Eivind Hovig; Ola Myklebost; Trond Stokke
Journal:  BMC Genomics       Date:  2004-02-03       Impact factor: 3.969

View more
  72 in total

1.  Simultaneous measurement of 10,000 protein-ligand affinity constants using microarray-based kinetic constant assays.

Authors:  James P Landry; Yiyan Fei; Xiangdong Zhu
Journal:  Assay Drug Dev Technol       Date:  2011-12-22       Impact factor: 1.738

2.  Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array.

Authors:  Francis Jacob; Darlene R Goldstein; Nicolai V Bovin; Tatiana Pochechueva; Marianne Spengler; Rosemarie Caduff; Daniel Fink; Marko I Vuskovic; Margaret E Huflejt; Viola Heinzelmann-Schwarz
Journal:  Int J Cancer       Date:  2011-04-25       Impact factor: 7.396

3.  Antibody repertoire profiling with mimotope arrays.

Authors:  Shina Pashova; Christoph Schneider; Stephan von Gunten; Anastas Pashov
Journal:  Hum Vaccin Immunother       Date:  2016-12-08       Impact factor: 3.452

4.  Diverse molecular recognition properties of blood group A binding monoclonal antibodies.

Authors:  Jeffrey C Gildersleeve; Whitney Shea Wright
Journal:  Glycobiology       Date:  2016-01-10       Impact factor: 4.313

5.  L-Rhamnose-containing supramolecular nanofibrils as potential immunosuppressive materials.

Authors:  Fan Zhao; Balthasar A Heesters; Isaac Chiu; Yuan Gao; Junfeng Shi; Ning Zhou; Michael C Carroll; Bing Xu
Journal:  Org Biomol Chem       Date:  2014-09-21       Impact factor: 3.876

6.  Exploring binding and effector functions of natural human antibodies using synthetic immunomodulators.

Authors:  Charles E Jakobsche; Christopher G Parker; Ran N Tao; Mariya D Kolesnikova; Eugene F Douglass; David A Spiegel
Journal:  ACS Chem Biol       Date:  2013-09-20       Impact factor: 5.100

7.  Serum glycan-binding IgG antibodies in HIV-1 infection and during the development of broadly neutralizing responses.

Authors:  Cathrine Scheepers; Sudipa Chowdhury; W Shea Wright; Christopher T Campbell; Nigel J Garrett; Quarraisha Abdool Karim; Salim S Abdool Karim; Penny L Moore; Jeffrey C Gildersleeve; Lynn Morris
Journal:  AIDS       Date:  2017-10-23       Impact factor: 4.177

8.  Glycan array analysis of the antigen repertoire targeted by tumor-binding antibodies.

Authors:  Jeffrey C Gildersleeve; Baomei Wang; Samuel Achilefu; Zhude Tu; Mai Xu
Journal:  Bioorg Med Chem Lett       Date:  2012-09-24       Impact factor: 2.823

9.  Synthesis and immunological evaluation of a MUC1 glycopeptide incorporated into l-rhamnose displaying liposomes.

Authors:  Sourav Sarkar; Alex C D Salyer; Katherine A Wall; Steven J Sucheck
Journal:  Bioconjug Chem       Date:  2013-03-08       Impact factor: 4.774

10.  Synthesis of a Liposomal MUC1 Glycopeptide-Based Immunotherapeutic and Evaluation of the Effect of l-Rhamnose Targeting on Cellular Immune Responses.

Authors:  Partha Karmakar; Kyunghee Lee; Sourav Sarkar; Katherine A Wall; Steven J Sucheck
Journal:  Bioconjug Chem       Date:  2015-12-09       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.